Overall Technical outlook

Price Summary

On 2025-12-15, Dr. Lal PathLabs Limited's shares started at 2898.0, peaked at 2915.0, bottomed out at 2825.0, and ended -1.34% lower at 2859.1, with 161834 shares traded.
The highest price the stock achieved in the past 52 weeks is 3473.5, while the lowest price it saw is 2310.45.
The price outlook for LALPATHLAB is between 2400.0 and 4000.0, with an average expectation of 3428.1538, as estimated by 26 analysts.

Technicals


Aroon: Aroon's bearish trend continues, with Aroon Down holding steady at the 100 level. This suggests ongoing weakness, but further exploration with other indicators is needed to fully assess the trend's implications.
LALPATHLAB aroon c118a2
Aroon chart for Dr. Lal PathLabs Limited


Bol. Bands: The current reading of the BOLL BANDS is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
LALPATHLAB bbands c118a2
Bolinger Bands chart for Dr. Lal PathLabs Limited


Parabolic SAR: The PSAR for LALPATHLAB remains bearish, establishing a key resistance level that could hinder upward movement. This ongoing bearish outlook suggests that the market may face challenges in breaking higher, with the resistance level acting as a barrier to potential gains.
LALPATHLAB psar c118a2
Parabolic Stop and Reverse chart for Dr. Lal PathLabs Limited


Stochastic: The K-line has crossed above the D-line on the stochastic indicator, while remaining below 20, indicating a possible bullish move. This pattern is often viewed as a signal that the market might start to rise from a low point, potentially leading to gains. Investors might see this as a favorable entry opportunity.
LALPATHLAB stoch c118a2
Stochastic chart for Dr. Lal PathLabs Limited


Tripple Moving Agerage: The moving averages for the 20-50-100 periods are aligned for a bullish trend, but the slopes of the faster averages indicate that this strength may be short-lived. The weakening momentum in the shorter-term averages suggests that a reversal could be approaching, signaling a potential shift in the trend.
LALPATHLAB trippleSMA c118a2
Tripple SMA chart for Dr. Lal PathLabs Limited


When evaluating a company's technical data, such as stock price charts or volume, it is essential to first consider its fundamentals. These fundamentals include financial stability, growth potential, and competitive advantages. Additionally, understanding the broader industry in which the company operates offers context that helps to make sense of technical patterns. By examining both the company's internal strengths and external environment, one can make more accurate and meaningful conclusions about its stock performance.